Evaluation of a commercial enzyme immunoassay for the detection of cryptococcal antigen.
A total of 143 cerebrospinal and serum samples, from proven and suspected cases of cryptococcosis, were concurrently examined using a recently introduced enzyme immunoassay (EIA Premier, Meridian Diagnostics, Inc., Cincinnati, OH, USA) and three latex agglutination (LA) procedures (Immunomycologics, Inc., Norman, OK, USA; IBL, Inc., Cranbury, NJ, USA and a non-commercial LA test). Of these 143 specimens, 115 were negative for cryptococcal antigen (CrAg) with the EIA and LA tests. The remaining 28 specimens were evaluated by the LA tests, and all were positive for CrAg (with titres ranging from 1:2 to 1:8192). Of these 28 LA-positive specimens, 26 were also tested by the EIA. This procedure detected CrAg in 23 specimens (88.5%), with antigen levels ranging from 1:4 to 1:266,857. There were 3 LA-positive specimens (tires 1:4 to 1:32) which were negative by the EIA procedure (10.7%). One LA-negative specimen demonstrated CrAg (titre 1:30) by the EIA procedure. The sensitivity of the EIA and LA tests was 85.2 and 100%, respectively. The specificity of the LA test was 100%, whereas that of the EIA was 97%. The agreement among laboratories for testing the specimens with the three LA tests was 100%.
Sekhon
A S
AS
National Centre for Human Mycotic Diseases, University of Alberta, Edmonton, Canada.
Garg
A K
AK
Kaufman
L
L
Kobayashi
G S
GS
Hamir
Z
Z
Jalbert
M
M
Moledina
N
N
D000946:Antigens, Fungal / Q000032:analysis*; D003453:Cryptococcosis / Q000175:diagnosis; D003455:Cryptococcus neoformans / Q000276:immunology*; D005069:Evaluation Studies as Topic; D006801:Humans; D007124:Immunoenzyme Techniques; D007841:Latex Fixation Tests; D012680:Sensitivity and Specificity
D000946:Antigens, Fungal